SELECTA BIOSCIENCES INC's ticker is SELB and the CUSIP is 816212104. A total of 97 filers reported holding SELECTA BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,489 | -36.7% | 4,235 | -33.2% | 0.00% | – |
| Q2 2023 | $7,097 | -66.7% | 6,337 | -58.7% | 0.00% | – |
| Q1 2023 | $21,343 | -70.4% | 15,355 | -65.0% | 0.00% | – |
| Q3 2022 | $72,000 | -34.5% | 43,905 | -47.8% | 0.00% | – |
| Q2 2022 | $110,000 | +22.2% | 84,093 | +15.2% | 0.00% | – |
| Q1 2022 | $90,000 | -50.5% | 73,027 | +30.8% | 0.00% | – |
| Q4 2021 | $182,000 | -47.7% | 55,835 | -32.9% | 0.00% | – |
| Q2 2021 | $348,000 | +145.1% | 83,201 | +165.2% | 0.00% | – |
| Q1 2021 | $142,000 | +238.1% | 31,377 | +125.6% | 0.00% | – |
| Q4 2020 | $42,000 | -4.5% | 13,908 | -22.1% | 0.00% | – |
| Q3 2020 | $44,000 | -70.9% | 17,857 | -66.4% | 0.00% | -100.0% |
| Q2 2020 | $151,000 | +55.7% | 53,115 | +31.8% | 0.00% | 0.0% |
| Q1 2020 | $97,000 | +1285.7% | 40,297 | +974.6% | 0.00% | – |
| Q2 2019 | $7,000 | -22.2% | 3,750 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +125.0% | 3,750 | +135.0% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 1,596 | +316.7% | 0.00% | – |
| Q3 2018 | $6,000 | – | 383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,773,479 | $4,965,000 | 3.90% |
| Silver Rock Financial LP | 457,850 | $820,000 | 0.20% |
| Artal Group S.A. | 2,100,000 | $3,759,000 | 0.15% |
| Proxima Capital Management, LLC | 41,300 | $74,000 | 0.10% |
| Vivo Capital, LLC | 546,054 | $977,000 | 0.09% |
| Orbimed Advisors | 2,879,064 | $5,154,000 | 0.08% |
| Fosun International Ltd | 438,330 | $824,000 | 0.05% |
| WASATCH ADVISORS LP | 2,551,033 | $4,566,000 | 0.04% |
| Man Group plc | 3,656,572 | $6,545,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 83,464 | $149,000 | 0.02% |